Clinical Trial Update: Comparative Antibiotic Therapy for Subjects With Pulmonary Infiltrates in the ICU [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating comparative antibiotic therapy for ICU patients with pulmonary infiltrates has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hospital-acquired Pneumonia
• Pneumonia

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Bacterial Infection | Phase 3 | Status: TERMINATED